Eikon Therapeutics

Eikon Therapeutics is a late-stage clinical biopharmaceutical company dedicated to inventing and developing breakthrough therapeutics. Based in Millbrae, California, we are pioneering novel therapies for patients with unmet medical needs, leveraging immune response modulation and synthetic lethality to improve cancer therapy.

Our approach centers on applying cutting-edge machine learning algorithms to large imaging datasets, accelerating the discovery of new targets and ultimately leading to the development of better medicines.

Eikon Therapeutics is driven by a passionate team of scientists and engineers committed to transforming fundamental disease biology into impactful treatments. We are focused on advancing our clinical programs and expanding our research capabilities to deliver life-changing therapies.